1. Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. (6th March 2021) Authors: Fujiwara, Yutaka; Kenmotsu, Hirotsugu; Yamamoto, Noboru; Shimizu, Toshio; Yonemori, Kan; Ocampo, Christopher; Parikh, Apurvasena; Okubo, Sumiko; Fukasawa, Kazuteru; Murakami, Haruyasu Journal: Cancer medicine Issue: Volume 10:Number 7(2021) Page Start: 2350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗